Health AI Central
Share:
Peer-Reviewed Publication
Schizophr Res2026August 18, 2026Published Erratum

Corrigendum to "exploratory anchor-based analyses to determine minimal clinically important differences for the brief assessment of cognition in schizophrenia and the schizophrenia cognition rating scale" [Schizophr. Res. 2026 July 25. doi:10.1016/j.schres.2026.07.021. Epub ahead of print].

Hans S Klein1, Reuben H Fan2, Tingting Ge2, Mahnaz Asgharnejad3, Chris Brady4, Elizabeth Hanson3, Philip D Harvey5, Jan Sedway4, Venkatesha Murthy3, Richard S E Keefe6, Jaskaran B Singh2, Ni A Khin2
1Neurocrine Biosciences, Inc., San Diego, CA, USA. Electronic address: hklein@neurocrine.com.
2Neurocrine Biosciences, Inc., San Diego, CA, USA.
3Takeda Development Center Americas, Inc., Cambridge, MA, USA.
4Clario, Philadelphia, PA, USA.
5Department of Psychiatry, University of Miami Miller School of Medicine, Miami, FL, USA.
6Duke University, Durham, NC, USA.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.